| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | NOVAVAX INC COM | 770,000 | 6,460,000 | 0.49% | ||
| 52 | COHERUS BIOSCIENCES INC COM | 282,000 | 6,475,000 | 0.49% | ||
| 53 | TANDEM DIABETES CARE INC COM | 562,500 | 6,643,000 | 0.50% | ||
| 54 | MACROGENICS INC | 218,000 | 6,751,000 | 0.51% | ||
| 55 | HEALTHSOUTH CORP | 195,000 | 6,788,000 | 0.51% | ||
| 56 | NOVADAQ TECHNOLOGIES INC | 540,000 | 6,880,000 | 0.52% | ||
| 57 | RELYPSA INC | 252,000 | 7,142,000 | 0.54% | ||
| 58 | BIOMARIN PHARMACEUTICAL INC | 70,000 | 7,333,000 | 0.56% | ||
| 59 | RTI SURGICAL HOLDINGS INC COM | 1,860,000 | 7,384,000 | 0.56% | ||
| 60 | Intersect ENT Inc | 337,293 | 7,589,000 | 0.58% | ||
| 61 | INSMED INC | 432,500 | 7,850,000 | 0.59% | ||
| 62 | GW PHARMACEUTICALS PLC | 116,000 | 8,055,000 | 0.61% | ||
| 63 | Heartware International, Inc. | 160,669 | 8,098,000 | 0.61% | ||
| 64 | INOVALON HLDGS INC COM CL A | 477,300 | 8,114,000 | 0.61% | ||
| 65 | PORTOLA PHARMACEUTICALS INC | 165,000 | 8,489,000 | 0.64% | ||
| 66 | VALEANT PHARMACEUTICALS INTL | 83,700 | 8,508,000 | 0.64% | ||
| 67 | SERES THERAPEUTICS INC | 245,400 | 8,611,000 | 0.65% | ||
| 68 | JUNO THERAPEUTICS INC COM | 197,001 | 8,662,000 | 0.66% | ||
| 69 | Anacor Pharmaceuticals Inc | 77,000 | 8,699,000 | 0.66% | ||
| 70 | VERTEX PHARMACEUTICALS INC | 72,750 | 9,154,000 | 0.69% | ||
| 71 | ADAPTIMMUNE THERAPEUTICS PLC | 765,001 | 9,226,000 | 0.70% | ||
| 72 | IDEXX LAB | 127,500 | 9,297,000 | 0.70% | ||
| 73 | CHIASMA INC | 487,500 | 9,540,000 | 0.72% | ||
| 74 | CARDIOME PHARMA CORP | 1,190,000 | 9,651,000 | 0.73% | ||
| 75 | INTRA-CELLULAR THERAPIES INC | 180,000 | 9,682,000 | 0.73% | ||
| 76 | INSYS THERAPEUTICS INC NEW COM NEW | 338,500 | 9,691,000 | 0.73% | ||
| 77 | DERMIRA INC COM | 290,000 | 10,037,000 | 0.76% | ||
| 78 | Theravance Biopharma Inc | 645,000 | 10,572,000 | 0.80% | ||
| 79 | Wright Medical Group NV | 456,000 | 11,026,000 | 0.84% | ||
| 80 | PENUMBRA INC COM | 205,000 | 11,031,000 | 0.84% | ||
| 81 | JAZZ PHARMACEUTICALS PLC | 80,300 | 11,287,000 | 0.86% | ||
| 82 | PRA HEALTH SCIENCES INC | 253,000 | 11,453,000 | 0.87% | ||
| 83 | ADURO BIOTECH INC | 415,000 | 11,678,000 | 0.88% | ||
| 84 | ULTRAGENYX PHARMACEUTICAL INC COM | 105,500 | 11,835,000 | 0.90% | ||
| 85 | ACHILLION PHARMACEUTICALS IN | 1,105,000 | 11,923,000 | 0.90% | ||
| 86 | THERAPEUTICSMD INC | 1,185,000 | 12,288,000 | 0.93% | ||
| 87 | ARDELYX INC COM | 682,500 | 12,367,000 | 0.94% | ||
| 88 | RETROPHIN INC | 675,000 | 13,021,000 | 0.99% | ||
| 89 | AMGEN INC | 80,900 | 13,132,000 | 1.00% | ||
| 90 | GALAPAGOS NV | 210,000 | 13,205,000 | 1.00% | ||
| 91 | INCYTE CORP | 127,000 | 13,773,000 | 1.04% | ||
| 92 | MEDNAX INC | 193,000 | 13,830,000 | 1.05% | ||
| 93 | THERMO FISHER SCIENTIFIC INC | 100,000 | 14,185,000 | 1.07% | ||
| 94 | MCKESSON CORP | 72,500 | 14,299,000 | 1.08% | ||
| 95 | BIOGEN INC | 50,650 | 15,517,000 | 1.18% | ||
| 96 | WELLCARE HEALTH PLANS INC | 214,500 | 16,776,000 | 1.27% | ||
| 97 | ANTHEM INC | 120,800 | 16,844,000 | 1.28% | ||
| 98 | PROTHENA CORP PLC | 248,000 | 16,891,000 | 1.28% | ||
| 99 | TESARO INCORPORATED | 334,000 | 17,475,000 | 1.32% | ||
| 100 | CIGNA CORPORATION | 122,000 | 17,852,000 | 1.35% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002886, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
